Assessment of pulmonary fibrosis using weighted gene co-expression network analysis
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces novel multi-gene biomarkers for identifying chemicals that cause lung fibrosis. These biomarkers, derived from gene expression analysis, enable efficient screening and prioritization of industrial chemicals.
Area Of Science
- Toxicology
- Biomarker Discovery
- Computational Biology
Background
- Sparse toxicological data exists for many industrial chemicals, necessitating new methods for chemical safety assessment.
- There is a high demand for New Approach Methodologies (NAMs) for screening and prioritizing chemicals regarding regulatory endpoints like lung fibrosis.
Purpose Of The Study
- To propose and validate multi-gene biomarkers for assessing a compound's potential to induce lung fibrosis.
- To demonstrate the application of these biomarkers for *in vitro* screening of industrial chemicals.
Main Methods
- Weighted gene co-expression network analysis (WGCNA) was used to reanalyze mouse pulmonary gene expression data from bleomycin-induced lung fibrosis.
- Eight gene modules associated with different phases of fibrosis development were identified.
- Module relevance was confirmed by comparison with known lung fibrosis markers from DisGeNET.
Main Results
- Eight gene modules, ranging from 58 to 273 genes, were identified and linked to inflammatory and fibrotic phases of lung fibrosis.
- The identified modules demonstrated differential activation in response to known lung fibrosis-inducing diketones in an *in vitro* assay.
- A dose-dependent increase in module activation was observed for fibrotic diketones, distinguishing them from non-fibrotic compounds.
Conclusions
- Composite biomarkers derived from multi-gene modules show potential for mechanistic screening of chemical-induced lung fibrosis.
- This approach offers a promising New Approach Methodology (NAM) for evaluating chemical safety and prioritizing compounds.
- The study highlights the utility of gene expression-based biomarkers for toxicological assessments.

